Replies to post #58240 on Enzolytics Inc (ENZC)

[BluE33]

Great! OTCShotCaller what do you think of this?:

Bioclonetics CL3 was acquired 05/02 by BTG PLC for their HIV Portfolio, a Boston Scientific subsidiary, which was acquired at $4B.

A licensing agreement?:

$ENZC Bioclonetics CL3 was acquired 05/02 by BTG PLC for their HIV Portfolio, a Boston Scientific subsidiary, which was acquired at $4B. #BostonScientific #BTGPLC #FDA #NIH #BARDA #TAMU #MABS #ViiVHealthcare #HIV #AIDS #BillGates #Gilead #Merck #Pfizer #GoldmanSachs$BSX $TMO pic.twitter.com/zpWgRrJHTK

— WolfOfOTC (@WolfOfOTC) December 19, 2020

$ENZC

[bluebird50]

Hey OTC, is it possible that the transition to BTS could (possibly) be the result of a request from say a larger company?? That is interested in making ties with us? Just a thought I had from your post!
Or are they more accredited with inroads with the FDA?
Or are they more timely with producing results?
Thanks for entertaining....

[BonnieMac]

OTC SC~ Did I understand you correctly to say that ENZC's PPS will be only $1 to $2 this Spring? With all the "hoopla" & posting in here, I would've thought the PPS would be a lot higher by then!